Clinical Trial Update: Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/Phase 2 trial of MOR103 for multiple sclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MOR103

Snippet

Sponsor: MorphoSys AG | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-13